Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion type Assertion NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_head.
- NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_provenance.
- NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion evidence source_evidence_literature NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_provenance.
- NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion SIO_000772 8639762 NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_provenance.
- NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion wasDerivedFrom befree-20140225 NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_provenance.
- NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_assertion wasGeneratedBy ECO_0000203 NP378825.RANbVNfS5mMeOCJgW1SAxImsI33VtO39wAccl8vGX7sYs130_provenance.